More on NGNE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.9 Score)

Upcoming Events

- Earnings (11/12/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Neurogene (NQ:NGNE)
Delayed: 22.17 +0.04 (0.18%)
Prev. Close $22.13  
Open$21.38 
52 Wk High$ 
52 Wk Low$ 
Day High$23.18 
Day Low$21.23 
P/E N/A  
EPS$ 
Volume114,087 

Friends, Peers and Foes (?): TSHA, BMRN, DNLI, DYN, LXEO (more...)

Mar 3, 2026 05:04 PM Form 4 Neurogene Inc. For: Feb 27 Filed by: Cvijic Christine Mikail
Mar 3, 2026 04:01 PM Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Feb 27, 2026 04:51 PM Form 144 Neurogene Inc. Filed by: Cvijic Christine Mikail
Feb 26, 2026 04:03 PM Form 8-K Neurogene Inc. For: Feb 26
Feb 26, 2026 04:01 PM Neurogene receives FDA breakthrough therapy designation for Rett syndrome drug
Feb 26, 2026 04:01 PM Neurogene Announces FDA Breakthrough Therapy Designation for NGN-401 Gene Therapy for Rett Syndrome
Feb 24, 2026 06:50 PM Form 4 Neurogene Inc. For: Feb 20 Filed by: Cobb Stuart
Feb 24, 2026 06:49 PM Form 4 Neurogene Inc. For: Feb 20 Filed by: Jordan Julie
Feb 24, 2026 06:49 PM Form 4 Neurogene Inc. For: Feb 20 Filed by: Cvijic Christine Mikail
Feb 24, 2026 06:48 PM Form 4 Neurogene Inc. For: Feb 20 Filed by: McMinn Rachel
View All Articles

Entities mentioned with NGNE

View All Entities